Literature DB >> 1730738

The site of hydrolysis by rabbit reticulocyte peptidyl-tRNA hydrolase is the 3'-AMP terminus of susceptible tRNA substrates.

M Gross1, P Crow, J White.   

Abstract

The preceding paper (Gross, M., Starn, T.K., Rundquist, C., Crow, P., White, J., Olin, A., and Wagner, T. (1992) J. Biol. Chem. 267, 2073-2079) reported the purification and partial characterization of rabbit reticulocyte peptidyl-tRNA hydrolase. In this article we demonstrate that, unlike bacterial and yeast peptidyl-tRNA hydrolase which act by deacylation, the reticulocyte enzyme hydrolyzes N-acylaminoacyl-tRNA to N-acylaminoacyl-AMP. Reticulocyte lysate has a separate enzyme, that we have isolated and termed aminoacyl-AMP deacylase, which hydrolyzes N-acylaminoacyl-AMP and aminoacyl-AMP, recycling the amino acid and nucleotide components. The action of this enzyme is relatively specific for the N-acylaminoacyl-AMP generated by peptidyl-tRNA hydrolase, since it is much less active with N-acylaminoacyl-adenosine and inactive with N-acylaminoacyl-ACCAC, N-acylaminoacyl-tRNA, or aminoacyl-tRNA. The tRNA product of peptidyl-tRNA hydrolase action is tRNA missing only its 3'-AMP terminus (tRNA(c-c)), since reaminoacylation requires tRNA nucleotidyltransferase but not CTP. The 3' exonucleolytic action of reticulocyte peptidyl-tRNA hydrolase is specific to susceptible tRNA substrates, since it does not hydrolyze CACCA, CACCA-N-acylamino acid, polyuridylic acid, or the 3' polyadenylate tail of globin mRNA, and, since its ability to hydrolyze Escherichia coli f[3H]Met-tRNA(fMet) is not reduced by excess 5 S or 28 S ribosomal RNA and is reduced only slightly by excess tRNA(c-c). Reticulocyte peptidyl-tRNA hydrolase also hydrolyzes th 3'-AMP terminus of deacylated tRNA. This property may explain why the 3'-terminal AMP of tRNA undergoes turnover in reticulocytes and reticulocyte lysate, since we find that such turnover in gel-filtered reticulocyte lysate is increased under conditions where aminoacylation is reduced.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730738

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Ribosome release factor RF4 and termination factor RF3 are involved in dissociation of peptidyl-tRNA from the ribosome.

Authors:  V Heurgué-Hamard; R Karimi; L Mora; J MacDougall; C Leboeuf; G Grentzmann; M Ehrenberg; R H Buckingham
Journal:  EMBO J       Date:  1998-02-02       Impact factor: 11.598

2.  Crystal structure at 1.2 A resolution and active site mapping of Escherichia coli peptidyl-tRNA hydrolase.

Authors:  E Schmitt; Y Mechulam; M Fromant; P Plateau; S Blanquet
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

3.  3'-immature tRNA(Trp) is required for ribosome inactivation by gelonin,a plant RNA N-glycosidase.

Authors:  M Brigotti; D Carnicelli; P Alvergna; A Pallanca; R Lorenzetti; M Denaro; S Sperti; L Montanaro
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

4.  Peptidyl-tRNA hydrolase from Sulfolobus solfataricus.

Authors:  Michel Fromant; Maria-Laura Ferri-Fioni; Pierre Plateau; Sylvain Blanquet
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

5.  A physiological connection between tmRNA and peptidyl-tRNA hydrolase functions in Escherichia coli.

Authors:  Nongmaithem Sadananda Singh; Umesh Varshney
Journal:  Nucleic Acids Res       Date:  2004-11-16       Impact factor: 16.971

6.  Small molecule binding, docking, and characterization of the interaction between Pth1 and peptidyl-tRNA.

Authors:  Mary C Hames; Hana McFeeters; W Blake Holloway; Christopher B Stanley; Volker S Urban; Robert L McFeeters
Journal:  Int J Mol Sci       Date:  2013-11-19       Impact factor: 5.923

7.  Small Molecule Docking Supports Broad and Narrow Spectrum Potential for the Inhibition of the Novel Antibiotic Target Bacterial Pth1.

Authors:  Paul P Ferguson; W Blake Holloway; William N Setzer; Hana McFeeters; Robert L McFeeters
Journal:  Antibiotics (Basel)       Date:  2016-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.